Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan · Delayed Price · Currency is TWD 8.62
-0.38 (-4.22%)
Oct 30, 2026, 1:50 PM CST
Meribank Biotech Market Cap
Meribank Biotech has a market cap or net worth of 837.87 million as of October 30, 2026. It is the 34,742nd most valuable company in the world and the 2,095th biggest in Taiwan. Its market cap has decreased by 48.66% in one year.
Market Cap
837.87M
Enterprise Value
388.60M
Revenue
408.48M
Global Rank
Country Rank
#2,095 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 16, 2023, Meribank Biotech's market cap has decreased from 1.95B to 837.87M, a decrease of -56.95%. That is a compound annual growth rate of -22.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 837.87M | -41.75% |
| Dec 31, 2025 | 1.44B | -41.61% |
| Dec 31, 2024 | 2.46B | 2.99% |
| Dec 29, 2023 | 2.39B | 22.90% |
| Jun 16, 2023 | 1.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Level Biotechnology | 993.06M |
| BiOptic | 992.66M |
| GeneReach Biotechnology | 938.16M |
| Holy Stone Healthcare | 934.23M |
| MegaPro Biomedical | 906.09M |
| Lukas Biomedical | 778.86M |
| TCI GENE | 772.51M |
| NatureWise Biotech & Medicals | 751.08M |